PFM Health Sciences’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.32M | Sell |
13,351
-514
| -4% | -$259K | 0.58% | 56 |
|
|
2025
Q4 | $6.47M | Sell |
13,865
-51,908
| -79% | -$24.1M | 0.65% | 48 |
|
|
2025
Q3 | $28M | Sell |
65,773
-6,517
| -9% | -$2.53M | 2.16% | 12 |
|
|
2025
Q2 | $27.7M | Sell |
72,290
-5,174
| -7% | -$1.86M | 2.36% | 14 |
|
|
2025
Q1 | $26.8M | Buy |
77,464
+8,023
| +12% | +$2.58M | 1.94% | 18 |
|
|
2024
Q4 | $20.8M | Sell |
69,441
-55,399
| -44% | -$19.4M | 1.29% | 27 |
|
|
2024
Q3 | $50.7M | Hold |
124,840
| – | – | 2.88% | 8 |
|
|
2024
Q2 | $40.1M | Hold |
124,840
| – | – | 1.98% | 13 |
|
|
2024
Q1 | $41.6M | Hold |
124,840
| – | – | 1.96% | 14 |
|
|
2023
Q4 | $33.8M | Buy |
124,840
+5,305
| +4% | +$1.31M | 2.03% | 17 |
|
|
2023
Q3 | $29.4M | Sell |
119,535
-39,237
| -25% | -$10.7M | 1.39% | 33 |
|
|
2023
Q2 | $48.2M | Buy |
158,772
+10,272
| +7% | +$2.86M | 1.87% | 19 |
|
|
2023
Q1 | $39.2M | Buy |
148,500
+56,555
| +62% | +$14.4M | 1.73% | 22 |
|
|
2022
Q4 | $22.1M | Sell |
91,945
-83,290
| -48% | -$18.7M | 0.79% | 49 |
|
|
2022
Q3 | $32.2M | Buy |
+175,235
| New | +$34.9M | 1.17% | 39 |
|
|
2022
Q2 | – | Sell |
-80,128
| Closed | -$20.1M | – | 84 |
|
|
2022
Q1 | $20.1M | Sell |
80,128
-115,493
| -59% | -$29M | 0.75% | 47 |
|
|
2021
Q4 | $50.3M | Sell |
195,621
-194,886
| -50% | -$47.7M | 1.71% | 23 |
|
|
2021
Q3 | $94.8M | Hold |
390,507
| – | – | 2.79% | 8 |
|
|
2021
Q2 | $80.7M | Hold |
390,507
| – | – | 2.53% | 10 |
|
|
2021
Q1 | $73.5M | Buy |
390,507
+77,020
| +25% | +$13.6M | 2.25% | 10 |
|
|
2020
Q4 | $51.6M | Sell |
313,487
-51,453
| -14% | -$7.52M | 1.81% | 19 |
|
|
2020
Q3 | $45.5M | Buy |
364,940
+35,583
| +11% | +$4.4M | 2.1% | 11 |
|
|
2020
Q2 | $32M | Buy |
329,357
+143,508
| +77% | +$14.9M | 1.66% | 23 |
|
|
2020
Q1 | $16.7M | Sell |
185,849
-93,562
| -33% | -$12.1M | 1.37% | 30 |
|
|
2019
Q4 | $41.3M | Sell |
279,411
-137,322
| -33% | -$18.4M | 1.97% | 19 |
|
|
2019
Q3 | $50.2M | Sell |
416,733
-213,034
| -34% | -$27.5M | 1.48% | 27 |
|
|
2019
Q2 | $85.1M | Buy |
629,767
+342,816
| +119% | +$43.3M | 1.62% | 19 |
|
|
2019
Q1 | $37.4M | Sell |
286,951
-104,854
| -27% | -$14.1M | 0.83% | 40 |
|
|
2018
Q4 | $48.8M | Sell |
391,805
-127,354
| -25% | -$17.1M | 1.3% | 32 |
|
|
2018
Q3 | $72.2M | Sell |
519,159
-3,186
| -0.6% | -$397K | 1.06% | 39 |
|
|
2018
Q2 | $53.6M | Sell |
522,345
-63,106
| -11% | -$6.38M | 0.84% | 42 |
|
|
2018
Q1 | $56.8M | Sell |
585,451
-146,556
| -20% | -$14.2M | 1.15% | 31 |
|
|
2017
Q4 | $64.3M | Buy |
+732,007
| New | +$58.8M | 1.53% | 26 |
|
|
2016
Q4 | – | Sell |
-277,352
| Closed | -$21M | – | 104 |
|
|
2016
Q3 | $21M | Sell |
277,352
-365,521
| -57% | -$28M | 0.61% | 56 |
|
|
2016
Q2 | $49.5M | Sell |
642,873
-1,395,315
| -68% | -$110M | 1.49% | 28 |
|
|
2016
Q1 | $159M | Buy |
2,038,188
+1,636,371
| +407% | +$114M | 4.91% | 1 |
|
|
2015
Q4 | $27.2M | Sell |
401,817
-1,965,209
| -83% | -$137M | 0.83% | 40 |
|
|
2015
Q3 | $183M | Buy |
2,367,026
+321,743
| +16% | +$28.5M | 5.15% | 2 |
|
|
2015
Q2 | $186M | Buy |
2,045,283
+1,089,523
| +114% | +$87.3M | 4.7% | 2 |
|
|
2015
Q1 | $71.9M | Sell |
955,760
-930,806
| -49% | -$66.8M | 1.98% | 16 |
|
|
2014
Q4 | $138M | Sell |
1,886,566
-901,378
| -32% | -$63.4M | 3.23% | 4 |
|
|
2014
Q3 | $197M | Sell |
2,787,944
-769,804
| -22% | -$50.9M | 4.53% | 5 |
|
|
2014
Q2 | $201M | Sell |
3,557,748
-1,206,080
| -25% | -$63.6M | 4.01% | 6 |
|
|
2014
Q1 | $250M | Buy |
4,763,828
+1,185,823
| +33% | +$59M | 4.53% | 4 |
|
|
2013
Q4 | $171M | Buy |
3,578,005
+908,581
| +34% | +$42M | 3.43% | 9 |
|
|
2013
Q3 | $114M | Sell |
2,669,424
-1,750,144
| -40% | -$68.4M | 2.75% | 12 |
|
|
2013
Q2 | $159M | Buy |
+4,419,568
| New | +$171M | 3.31% | 8 |
|
Other funds holding HCA
VCM
VPM
PFM Health Sciences's HCA Position: Q1 2026 in Review
PFM Health Sciences reduced its HCA Healthcare (HCA) stake by 3.7% in Q1 2026, selling an estimated $259K and leaving 13,351 shares worth $6.32M. The position accounts for 0.58% of the portfolio, ranked #56.
PFM Health Sciences first reported a position in HCA in Q2 2013 and has held it in 47 quarters since. The position peaked at $250M in Q1 2014. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- PFM Health Sciences held 13,351 shares of HCA Healthcare worth $6.32M as of Q1 2026.
- PFM Health Sciences sold 514 HCA Healthcare shares in Q1 2026, an estimated $259K.
- HCA Healthcare made up 0.58% of PFM Health Sciences's portfolio in Q1 2026, its #56 holding.
- PFM Health Sciences first reported a position in HCA Healthcare in Q2 2013 and has held it in 47 quarters since.
- PFM Health Sciences's HCA Healthcare position peaked at $250M in Q1 2014.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.